Quantum Biopharma Class B Subordinate Voting Shares
QNTM
11 hedge funds and large institutions have $516K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
1,640% more call options, than puts
Call options by funds: $87K | Put options by funds: $5K
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
21% less funds holding
Funds holding: 14 → 11 (-3)
28% less capital invested
Capital invested by funds: $714K → $516K (-$197K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$44.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.8K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$429 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$43.7K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$24.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$16K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.52K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$772 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $287K | -$43.7K | -509 | -12% |
|
|
2
Renaissance Technologies
New York
| $118K | +$44.3K | +516 | +49% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $66.1K | +$29.8K | +347 | +65% |
|
4
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $17K | – | – | – |
|
|
TWC
5
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $12K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $11.7K | -$16K | -187 | -55% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$429 | +5 | +18% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $1.15K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $883 | -$86 | -1 | -8% |
|
10
National Bank of Canada
Montreal,
Quebec, Canada
| $816 | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| $1 | -$772 | -9 | Closed |
|
|
12
Group One Trading
Chicago,
Illinois
| – | -$24.6K | -287 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$3.52K | -41 | Closed |
|
|
ASN
14
Advisory Services Network
Atlanta,
Georgia
| – | -$37 | – | – |
|
QNTM Hedge Fund Activity: Q2 2023 in Review
11 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q2 2023, worth a combined $516K — down 28% from $714K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of QNTM and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $44.3K. The largest seller was AdvisorShares Investments, cutting an estimated $43.7K.
- 11 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q2 2023, down from 14 in Q1 2023.
- Funds reported $516K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q2 2023, down 28% quarter-over-quarter.
- 0 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q2 2023 and 3 closed out, a net change of -3 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q2 2023 was Renaissance Technologies, an estimated $44.3K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q2 2023 was AdvisorShares Investments, an estimated $43.7K sold.
Based on aggregated 13F filings for Q2 2023.